Noble Life Sciences is Granted Renewal of Full Accreditation from AAALAC
Sykesville, MD, March 13, 2020 – Noble Life Sciences is excited to announce renewal of full accreditation from Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council. Noble Life Sciences has held full AAALAC accreditation since October 10, 1989. Accredited contract research organizations (CROs) are re-evaluated every three years through an extensive internal review and on-site inspection conducted by members of AAALAC accreditation council and reviewed by the full council to determine accreditation status.
AAALAC accreditation is a voluntary process that Noble Life Sciences takes part in to affirm adherence to the highest standards for animal care, in addition to complying with local, state and federal laws that regulate animal research. AAALAC assessment evaluates all aspects of animal care and use program- including institutional policies, animal housing, veterinary care and facilities. To maintain AAALAC accreditation, Noble Life Sciences proactively provides information in respect to animal care programs and studies.
AAALAC International Council on Accreditation President, Bart Carter, commended Noble Life Sciences in his accreditation letter for “strong administrative commitment…as evidenced in part by the active and engaged Institutional Official; the conscientious and highly qualified staff; the active and engaged Institutional Animal Care and Use Committee; and the appearance of healthy and well cared for animals.”
AAALAC International is a private, nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. More than 1,000 agencies -from companies and hospitals to research institutions- in 49 countries have earned AAALAC accreditation, demonstrating their commitment to responsible animal care and use.
About Noble Life Sciences
Noble Life Sciences is a leading contract research organization providing integrated GLP and non-GLP preclinical services designed to accelerate development of drugs, vaccines and medical devices. Services include but are not limited to pharmacology, disease models, early safety assessments, toxicology, and GLP custom polyclonal antibodies. Other services include the derivation and maintenance of animal breeding colonies, animal housing and husbandry, development of disease and animal models. Noble Life Sciences is committed to high quality animal care program that is backed by AAALAC accreditation, OLAW assurance, a USDA license and over 50 years of experience. For more information, visit us at https://noblelifesci.com/